Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Minority Interest (2024 - 2026)

Usana Health Sciences (USNA) has disclosed Minority Interest for 3 consecutive years, with $53.2 million as the latest value for Q1 2026.

  • Quarterly Minority Interest fell 1.95% to $53.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53.2 million through Jan 2026, down 1.95% year-over-year, with the annual reading at $53.2 million for FY2026, 1.95% down from the prior year.
  • Minority Interest for Q1 2026 was $53.2 million at Usana Health Sciences, down from $53.5 million in the prior quarter.
  • The five-year high for Minority Interest was $54.5 million in Q2 2025, with the low at $53.2 million in Q1 2026.
  • Average Minority Interest over 3 years is $53.9 million, with a median of $54.1 million recorded in 2025.
  • Peak annual rise in Minority Interest hit 1.95% in 2026, while the deepest fall reached 1.95% in 2026.
  • Over 3 years, Minority Interest stood at $54.2 million in 2024, then decreased by 1.37% to $53.5 million in 2025, then fell by 0.58% to $53.2 million in 2026.
  • According to Business Quant data, Minority Interest over the past three periods came in at $53.2 million, $53.5 million, and $54.5 million for Q1 2026, Q3 2025, and Q2 2025 respectively.